Corlanor is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Ivabradine Hydrochloride.
| Product ID | 55513-810_17727cc4-117c-47b3-bf1d-bbc2968c51b6 | 
| NDC | 55513-810 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Corlanor | 
| Generic Name | Ivabradine | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2015-04-20 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206143 | 
| Labeler Name | Amgen Inc | 
| Substance Name | IVABRADINE HYDROCHLORIDE | 
| Active Ingredient Strength | 8 mg/1 | 
| Pharm Classes | Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC],Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2015-04-20 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206143 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-04-20 | 
| Marketing Category | NDA | 
| Application Number | NDA206143 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-04-20 | 
| Ingredient | Strength | 
|---|---|
| IVABRADINE HYDROCHLORIDE | 7.5 mg/1 | 
| SPL SET ID: | 92018a65-38f6-45f7-91d4-a34921b81d0d | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 55513-800 | Corlanor | ivabradine | 
| 55513-810 | Corlanor | ivabradine | 
| 55513-813 | Corlanor | ivabradine | 
| 70518-3309 | Corlanor | ivabradine | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() CORLANOR  79157808  4834147 Live/Registered  | 
        BIOFARMA  2014-10-03  | 
![]() CORLANOR  77684533  3751418 Live/Registered  | 
        BIOFARMA  2009-03-05  |